Dolezal J
Department of Nuclear Medicine, University Hospital, Sokolska 581, Hradec Kralove, Czech Republic.
Nuklearmedizin. 2008;47(4):175-7.
To assess a radiation exposure and the quality of radiation protection concerning a nuclear medicine staff at our department as a six-year retrospective study. Therapeutic radionuclides such as (131)I, (153)Sm, (186)Re, (32)P, (90)Y and diagnostic ones as a (99m)Tc, (201)Tl, (67)Ga, (111)In were used. MATERIAL, METHOD: The effective dose was evaluated in the period of 2001-2006 for nuclear medicine physicians (n = 5), technologists (n = 9) and radiopharmacists (n = 2). A personnel film dosimeter and thermoluminescent ring dosimeter for measuring (1-month periods) the personal dose equivalent Hp(10) and Hp(0,07) were used by nuclear medicine workers. The wearing of dosimeters was obligatory within the framework of a nationwide service for personal dosimetry. The total administered activity of all radionuclides during these six years at our department was 17,779 GBq ((99m)Tc 14 708 GBq, (131)I 2490 GBq, others 581 GBq). The administered activity of (99m)Tc was similar, but the administered activity of (131)I in 2006 increased by 200%, as compared with the year 2001.
The mean and one standard deviation (SD) of the personal annual effective dose (mSv) for nuclear medicine physicians was 1.9 +/- 0.6, 1.8 +/- 0.8, 1.2 +/- 0.8, 1.4 +/- 0.8, 1.3 +/- 0.6, 0.8 +/- 0.4 and for nuclear medicine technologists was 1.9 +/- 0.8, 1.7 +/- 1.4, 1.0 +/- 1.0, 1.1 +/- 1.2, 0.9 +/- 0.4 and 0.7 +/- 0.2 in 2001, 2002, 2003, 2004, 2005 and 2006, respectively. The mean (n = 2, estimate of SD makes little sense) of the personal annual effective dose (mSv) for radiopharmacists was 3.2, 1.8, 0.6, 1.3, 0.6 and 0.3. Although the administered activity of (131)I increased, the mean personal effective dose per year decreased during the six years.
In all three professional groups of nuclear medicine workers a decreasing radiation exposure was found, although the administered activity of (131)I increased during this six-year period. Our observations suggest successful radiation protection measures at our department.
作为一项为期六年的回顾性研究,评估我院核医学科工作人员的辐射暴露情况及辐射防护质量。使用了治疗性放射性核素,如(131)I、(153)Sm、(186)Re、(32)P、(90)Y,以及诊断性放射性核素,如(99m)Tc、(201)Tl、(67)Ga、(111)In。
对2001 - 2006年期间的核医学医师(n = 5)、技术人员(n = 9)和放射药剂师(n = 2)的有效剂量进行评估。核医学工作人员使用个人胶片剂量计和热释光指环剂量计来测量(为期1个月)个人剂量当量Hp(10)和Hp(0,07)。在全国个人剂量监测服务框架内,佩戴剂量计是强制性的。这六年期间我院所有放射性核素的总给药活度为17779GBq((99m)Tc 14708GBq,(131)I 2490GBq,其他581GBq)。(99m)Tc的给药活度相似,但与2001年相比,2006年(131)I的给药活度增加了200%。
核医学医师个人年度有效剂量(mSv)的均值及一个标准差(SD)在2001年、2002年、2003年、2004年、2005年和2006年分别为1.9±0.6、1.8±0.8、1.2±0.8、1.4±0.8、1.3±0.6、0.8±0.4;核医学技术人员分别为1.9±0.8、1.7±1.4、1.0±1.0、1.1±1.2、0.9±0.4、0.7±0.2。放射药剂师个人年度有效剂量(mSv)的均值(n = 2,标准差估计意义不大)为3.2、1.8、0.6、1.3、0.6、0.3。尽管(131)I的给药活度增加,但六年期间个人年均有效剂量下降。
在核医学工作人员的所有三个专业组中,尽管这六年期间(131)I的给药活度增加,但辐射暴露仍在减少。我们的观察表明我院的辐射防护措施是成功的。